Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Development of standard clinical endpoints for use in dengue interventional trials.

Tomashek KM, Wills B, See Lum LC, Thomas L, Durbin A, Leo YS, de Bosch N, Rojas E, Hendrickx K, Erpicum M, Agulto L, Jaenisch T, Tissera H, Suntarattiwong P, Collers BA, Wallace D, Schmidt AC, Precioso A, Narvaez F, Thomas SJ, Edelman R, Siqueira JB, Cassetti MC, Dempsey W, Gubler DJ.

PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006497. doi: 10.1371/journal.pntd.0006497. eCollection 2018 Oct.

2.

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.

Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L.

Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589.

3.

Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage - the MUSFIH study.

Poonnoose P, Carneiro JDA, Cruickshank AL, El Ekiaby M, Perez Bianco RP, Ozelo MC, De Bosch N, Baghaipour M, Tien SL, Chuansumrit A, D'Amico EA, van Zyl A, Sabour A, Candela M, Ricciardi JBS, Ruiz-Sàez A, Ravanbod R, Lam JCL, Jaovisidha S, Kavitha ML, Gibikote S, Shyamkumar N, Srivastava A; MUSFIH Study group.

Haemophilia. 2017 Jul;23(4):538-546. doi: 10.1111/hae.13242. Epub 2017 Jun 2.

PMID:
28574179
4.

A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutation.

Schmidt DJ, Pickett BE, Camacho D, Comach G, Xhaja K, Lennon NJ, Rizzolo K, de Bosch N, Becerra A, Nogueira ML, Mondini A, da Silva EV, Vasconcelos PF, Muñoz-Jordán JL, Santiago GA, Ocazionez R, Gehrke L, Lefkowitz EJ, Birren BW, Henn MR, Bosch I.

Infect Genet Evol. 2011 Dec;11(8):2011-9. doi: 10.1016/j.meegid.2011.09.010. Epub 2011 Sep 23.

5.

Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations.

Albánez S, Ruiz-Sáez A, Boadas A, de Bosch N, Porco A.

Haemophilia. 2011 Sep;17(5):e913-8. doi: 10.1111/j.1365-2516.2011.02500.x. Epub 2011 Mar 4.

PMID:
21371196
6.

Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.

Boadas A, Fernández-Palazzi F, De Bosch NB, Cedeño M, Ruiz-Sáez A.

Haemophilia. 2011 May;17(3):422-7. doi: 10.1111/j.1365-2516.2010.02427.x. Epub 2010 Dec 1.

PMID:
21118333
7.

Radiosynoviorthesis in haemophilia: how safe?

Fernández-Palazzi F, Viso R, Boadas A, Ruiz-Saez A, Falcon de Vargas A, de Bosch NB.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:39-42.

8.

Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case-control study in Venezuela.

Pestana CI, Torres A, Blanco S, Rojas MJ, Méndez C, López JL, de Bosch NB, Porco A.

Genet Test Mol Biomarkers. 2009 Aug;13(4):537-42. doi: 10.1089/gtmb.2008.0100.

PMID:
19604111
9.

Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.

Becerra A, Warke RV, Martin K, Xhaja K, de Bosch N, Rothman AL, Bosch I.

J Med Virol. 2009 Aug;81(8):1403-11. doi: 10.1002/jmv.21538.

10.

Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function.

Becerra A, Warke RV, Xhaja K, Evans B, Evans J, Martin K, de Bosch N, Rothman AL, Bosch I.

J Gen Virol. 2009 Apr;90(Pt 4):810-7. doi: 10.1099/vir.0.004416-0. Epub 2009 Mar 4.

11.

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group.

Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30.

PMID:
18976247
12.

Elevated levels of soluble ST2 protein in dengue virus infected patients.

Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I.

Cytokine. 2008 Feb;41(2):114-20. doi: 10.1016/j.cyto.2007.11.001. Epub 2008 Jan 28.

13.

Chemical synoviorthesis with oxytetracycline clorhydrate (Emicine) in recurrent haemarthrosis.

Fernández-Palazzi F, Cedeño M, Maldonado JC, Boadas A, De Saez AR, Chacal B F, De Bosch NB.

Haemophilia. 2008 Jan;14(1):21-4. Epub 2007 Nov 13.

PMID:
18005152
14.

Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.

Lopez-Johnston JC, de Bosch N, Scannone H, Rodríguez-Acosta A.

Ann Hematol. 2007 Dec;86(12):879-85. Epub 2007 Sep 22.

PMID:
17891398
15.

Inhibition of collagen, and thrombin-induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.

López-Johnston JC, de Bosch N, Scannone H, Rodríguez-Acosta A.

J Thromb Thrombolysis. 2007 Dec;24(3):275-82. Epub 2007 May 8.

PMID:
17486300
16.

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A.

J Thromb Haemost. 2005 Dec;3(12):2619-26. Erratum in: J Thromb Haemost. 2006 Apr;4(4):925.

17.

Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2.

Zhang B, McGee B, Yamaoka JS, Guglielmone H, Downes KA, Minoldo S, Jarchum G, Peyvandi F, de Bosch NB, Ruiz-Saez A, Chatelain B, Olpinski M, Bockenstedt P, Sperl W, Kaufman RJ, Nichols WC, Tuddenham EG, Ginsburg D.

Blood. 2006 Mar 1;107(5):1903-7. Epub 2005 Nov 22.

18.

Hemophilia treatment in developing countries: products and protocols.

Srivastava A, You SK, Ayob Y, Chuansumrit A, de Bosch N, Perez Bianco R, Ala F.

Semin Thromb Hemost. 2005 Nov;31(5):495-500. Review.

PMID:
16276456
21.

Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.

Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I.

J Virol. 2003 Nov;77(21):11822-32. Erratum in: J Virol. 2004 May;78(9):4947-8.

22.

Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex.

Zhang B, Cunningham MA, Nichols WC, Bernat JA, Seligsohn U, Pipe SW, McVey JH, Schulte-Overberg U, de Bosch NB, Ruiz-Saez A, White GC, Tuddenham EG, Kaufman RJ, Ginsburg D.

Nat Genet. 2003 Jun;34(2):220-5.

PMID:
12717434
23.

Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).

de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A.

Thromb Haemost. 2002 Aug;88(2):253-8.

PMID:
12195697
24.

Intra-articular hyaluronic acid in the treatment of haemophilic chronic arthropathy.

Fernández-Palazzi F, Viso R, Boadas A, Ruiz-Sáez A, Caviglia H, De Bosch NB.

Haemophilia. 2002 May;8(3):375-81.

PMID:
12010437
25.

Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.

Sekine O, Sugo T, Ebisawa K, Umeyama H, Iwahana H, Ruiz-Sáez A, de Bosch N, Matsudai M.

Thromb Haemost. 2002 Feb;87(2):282-7.

PMID:
11858488
26.

Synovectomy with rifampicine in haemophilic haemarthrosis.

Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A.

Haemophilia. 2000 Sep;6(5):562-5.

PMID:
11012702
27.

Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate.

Evatt B, Austin H, Leon G, Ruiz-Sáez A, de Bosch N.

Haemophilia. 2000 Jul;6 Suppl 1:128-32.

PMID:
10982279
28.

Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.

Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Piñango CL.

Thromb Haemost. 2000 Aug;84(2):263-70.

PMID:
10959699
29.

Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.

Marchi R, Mirshahi SS, Soria C, Mirshahi M, Zohar M, Collet JP, de Bosch NB, Arocha-Piñango CL, Soria J.

Thromb Res. 2000 Jul 15;99(2):187-93.

PMID:
10946093
30.

Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate.

Evatt BL, Austin H, Leon G, Ruiz-Sáez A, De Bosch N.

Haemophilia. 1999 Sep;5(5):295-300. Review. Erratum in: Haemophilia 2000 Sep;6(5):595.

PMID:
10583509
31.

ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.

Nichols WC, Terry VH, Wheatley MA, Yang A, Zivelin A, Ciavarella N, Stefanile C, Matsushita T, Saito H, de Bosch NB, Ruiz-Saez A, Torres A, Thompson AR, Feinstein DI, White GC, Negrier C, Vinciguerra C, Aktan M, Kaufman RJ, Ginsburg D, Seligsohn U.

Blood. 1999 Apr 1;93(7):2261-6.

PMID:
10090935
32.

Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.

Marchi R, Lundberg U, de Bosch NB, Arocha-Piñango CL.

Blood Coagul Fibrinolysis. 1998 Nov;9(8):733-9.

PMID:
9890716
33.

Dietary fatty acids in athero-thrombogenesis: influence of palm oil ingestion.

de Bosch NB, Bosch V, Apitz R.

Haemostasis. 1996 Oct;26 Suppl 4:46-54. Review.

PMID:
8979111
34.

Hematomas within the iliopsoas muscles in hemophilic patients: the Latin American experience.

Fernandez-Palazzi F, Hernandez SR, De Bosch NB, De Saez AR.

Clin Orthop Relat Res. 1996 Jul;(328):19-24.

PMID:
8653955
35.

Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.

Mancuso DJ, Tuley EA, Castillo R, de Bosch N, Mannucci PM, Sadler JE.

Thromb Haemost. 1994 Aug;72(2):180-5.

PMID:
7831648
36.

Six new cases of a caterpillar-induced bleeding syndrome.

Arocha-Piñango CL, de Bosch NB, Torres A, Goldstein C, Nouel A, Argüello A, Carvajal Z, Guerrero B, Ojeda A, Rodriguez A, et al.

Thromb Haemost. 1992 Apr 2;67(4):402-7.

PMID:
1378651
37.

An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation.

Maekawa H, Yamazumi K, Muramatsu S, Kaneko M, Hirata H, Takahashi N, de Bosch NB, Carvajal Z, Ojeda A, Arocha-Piñango CL, et al.

J Biol Chem. 1991 Jun 25;266(18):11575-81.

38.

HLA antigens in hemophiliacs A with or without factor VIII antibodies in a Venezuelan Mestizo population.

Simonney N, De Bosch N, Argueyo A, Garcia E, Layrisse Z.

Tissue Antigens. 1985 Apr;25(4):216-9.

PMID:
3925592
39.

Radioactive synovectomy in haemophilic haemarthrosis. Follow-up of fifty cases.

Fernandez-Palazzi F, de Bosch NB, de Vargas AF.

Scand J Haematol Suppl. 1984;40:291-300. No abstract available.

PMID:
6591396
40.

An abnormal fibrinogen in a Venezuelan family.

de Bosch NB, Arocha-Piñango CL, Soria J, Soria C, Rodríguez A, Rodríguez S.

Thromb Res. 1977 Feb;10(2):253-65. No abstract available.

PMID:
403631
41.

[Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].

Goldstein C, Sumoza A, De Bosch N, De Sanz N.

Sangre (Barc). 1973;18(3):313-21. Spanish. No abstract available.

PMID:
4757640
42.

[Functional and histopathological studies in the syndrome of faulty intestinal absorption].

BEKER S, VALENCIA-PARPARCEN J, CARBONELL L, BOSCH V, DE BOSCH NB, MONCADA PR.

Rev Med Chil. 1961 Nov;89:897-901. Spanish. No abstract available.

PMID:
13866658

Supplemental Content

Loading ...
Support Center